Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vikram Pattanayak

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Nature Methods|February 18, 2014
Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificityJohn P Guilinger, Vikram Pattanayak, Deepak Reyon, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2021
Analysis of off-target effects in CRISPR-based gene drives in the human malaria mosquitoWilliam T Garrood, Nace Kranjc, Karl Petri, et al.
Nucleic Acids Research|August 16, 2013
In silico abstraction of zinc finger nuclease cleavage profiles reveals an expanded landscape of off-target sitesJeffry D Sander, Cherie L Ramirez, Samantha J Linder, et al.
Nucleic Acids Research|February 19, 2005
Identification of antisense nucleic acid hybridization sites in mRNA molecules with self-quenching fluorescent reporter moleculesLida K Gifford, Joanna B Opalinska, David Jordan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 18, 2026
Clinical course and outcomes of antibody-mediated rejection after heart transplant in the contemporary eraBin Q Yang, Mahmoud Elesawy, Sofia Laux, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2019
Use of Routine Complete Blood Count Results to Rule Out Anaplasmosis Without the Need for Specific Diagnostic TestingSarah E Turbett, Melis N Anahtar, Vikram Pattanayak, et al.
Molecular Therapy. Nucleic Acids|May 4, 2022
CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer's disease <i>PSEN</i> <i>1</i> M146L mutationEvangelos Konstantinidis, Agnieszka Molisak, Florian Perrin, et al.
The CRISPR Journal|February 11, 2021
A Code of Ethics for Gene Drive ResearchGeorge J Annas, Chase L Beisel, Kendell Clement, et al.
Frontiers in Immunology|March 14, 2022
Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA VaccinationAyman Al Jurdi, Rodrigo B Gassen, Thiago J Borges, et al.
Human Immunology|March 3, 2023
COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates- a multicenter cohortGarrett R Roll, Robert A Bray, Matthew Cooper, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Nature Methods|February 18, 2014
Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificityJohn P Guilinger, Vikram Pattanayak, Deepak Reyon, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2021
Analysis of off-target effects in CRISPR-based gene drives in the human malaria mosquitoWilliam T Garrood, Nace Kranjc, Karl Petri, et al.
Nucleic Acids Research|August 16, 2013
In silico abstraction of zinc finger nuclease cleavage profiles reveals an expanded landscape of off-target sitesJeffry D Sander, Cherie L Ramirez, Samantha J Linder, et al.
Nucleic Acids Research|February 19, 2005
Identification of antisense nucleic acid hybridization sites in mRNA molecules with self-quenching fluorescent reporter moleculesLida K Gifford, Joanna B Opalinska, David Jordan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 18, 2026
Clinical course and outcomes of antibody-mediated rejection after heart transplant in the contemporary eraBin Q Yang, Mahmoud Elesawy, Sofia Laux, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2019
Use of Routine Complete Blood Count Results to Rule Out Anaplasmosis Without the Need for Specific Diagnostic TestingSarah E Turbett, Melis N Anahtar, Vikram Pattanayak, et al.
Molecular Therapy. Nucleic Acids|May 4, 2022
CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer's disease <i>PSEN</i> <i>1</i> M146L mutationEvangelos Konstantinidis, Agnieszka Molisak, Florian Perrin, et al.
The CRISPR Journal|February 11, 2021
A Code of Ethics for Gene Drive ResearchGeorge J Annas, Chase L Beisel, Kendell Clement, et al.
Frontiers in Immunology|March 14, 2022
Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA VaccinationAyman Al Jurdi, Rodrigo B Gassen, Thiago J Borges, et al.
Human Immunology|March 3, 2023
COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates- a multicenter cohortGarrett R Roll, Robert A Bray, Matthew Cooper, et al.
Pageof 3